Changes in TGF-beta1/Smads signaling pathway in rats with chemical hepatocarcinogenesis.
- Author:
Yun-peng HUA
1
;
Shao-qiang LI
;
Jia-ming LAI
;
Li-jian LIANG
;
Bao-gang PENG
;
Hui-zhen LIANG
;
Jie-fu HUANG
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Diethylnitrosamine; Liver Neoplasms, Experimental; chemically induced; metabolism; pathology; Male; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; metabolism; Smad4 Protein; metabolism; Smad7 Protein; metabolism; Transforming Growth Factor beta1; genetics; metabolism
- From: Journal of Southern Medical University 2008;28(10):1848-1852
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the changes in transforming growth factor beta 1 (TGF-beta1)/Smads signaling pathway in rats with chemical hepatocarcinogenesis.
METHODSFresh diethylnitrosamine (DENA) solution was administered in SD rats to induce hepatocellular carcinoma (HCC). The protein expressions of TGF-beta1, phosphorylated Smad2, Smad4 and Smad7 were detected in these rats with immunohistochemistry, and the mRNA expression of Smad4 was evaluated with RT-PCR.
RESULTSCirrhotic nodules occurred in the rats 8 weeks after DENA treatment, and HCC nodules were found 16 weeks after the treatment. In the normal liver tissue, very low levels of TGF-beta1 and Smad4 expressions, low Smad7 expression and high phosphorylated Smad2 expression were detected. The development of liver cirrhosis was accompanied by increased expressions of TGF-beta1, Smad4 and Smad7 but at 8 weeks after DENA treatment, the expression of phosphorylated Smad2 was significantly decreased, followed then by gradual increment till nearly the normal level. Twenty-two weeks after DENA treatment, Smad4 expression in liver tissue decreased markedly as compared with the levels at 8 and 16 weeks. The expressions of Smad4 and phosphorylated Smad2 in the HCC tissue was significantly lower than those in normal liver tissue.
CONCLUSIONHepatocarcinogenesis involves very complex mechanisms, can can be related partially to the decreased Smad4 and phosphorylated Smad2 expression and TGFbeta1 and Smad7 overexpression in advanced stage of liver cirrhosis.